Understanding PCOD: Causes and Symptoms

References

[1] Reena Wadia. Polycystic ovarian syndrome & periodontitis. British Dental Journal, 2020, 125.

[2] Fathima F Farook, Ka Ting Ng, Nuzaim MNM, Wen J Koh, Wan Y Teoh. Association of Periodontal Disease and Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis with Trial Sequential Analysis. Open Dentistry Journal, 2019, 1-7.

[3] Cecilia Fabiana Márquez-Arrico, Javier Silvestre Rangil, Milagros Rocha. Association between Periodontal Diseases and Polycystic Ovary Syndrome: A Systematic Review. Journal of Clinical Medicine, 2020, 1-12.

[4] Nina A, Zeib K et al. Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article, EUR J OBST.ET GYN R B., 2019; 3: 1-6).

[5] Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline, J Clin Endocrinol Metab, 2006; 91: 4237-4245.

[6] Adams JM, Taylor AE, Crowley WF Jr, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab, 2004; 89: 4343–4350.

[7] Christine Cortet- Rudelli; Didier Dewailly. “Diagnosis of Hyperandrogenism in Female Adolescents”. Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health.am. Retrieved, Sep, 21, 2006; 2006-11-21.

[8] Abdel Gadir A, Khatim MS, Mowafi RA, Alnaser HM, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries (1)-Correlation with basal hormonal profiles. Human Reproduction, 1992; 7: 453-7.

[9] Manvita IS, Sravani G, Sudhakar M, Bhavani B, Varma J, Uppala R, Aktar A. A prospective cross sectional observational study on prevalence of clinical manifestations. and hormonal abnormalities associated with polycystic ovarian disease: https://doi. org/10.54037/WJPS. 2021.91211. World Journal of Pharmaceutical Sciences, Dec. 1, 2021; 212-7.

[10] Shenoy PB, Brundha MP. Awareness of polycystic ovarian disease among females of age group 18-30 years. Journal of Pharmaceutical Sciences and Research, Aug. 1, 2016; 8(8): 813.

[11] Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of Polycystic Ovary Syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility. 2012;97(1):28- 38

[12] Zuo M, Liao G, Zhang W, Xu D, Lu J, Tang M, et al. Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring. J Ovarian Res. 2021;14(1):1-2

[13] Crosignani PG, Nicolosi AE. Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update. 2001; 7: 3-7

[14] Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA.1998; 95: 14956-60.

[15] Diamanti KE. Insulin resistance in PCOS. Endocrine. 2006; 30: 13 7. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008; 14: 367-78

[16] Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005; 366: 491-505.

[17] Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Poly-cystic ovary syndrome and the risk of gynecological cancer. a sys tematic review. Reprod Biomed Online. 2009; 19: 398-405.

[18] Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tu mors in a cohort of infertile women. N Engl J Med.1994; 331: 771-6.

[19] Atiomo W, El Mahdi E, Hardiman P. Familial associations in PCOS. Fertil Steril. 2003; 80: 143-5.

[20] Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Up date. 2001; 7: 522-5

[21] Dahlgren E, Johansson S, Lindstedt GK, Nutsson F, Oden A, Janson PO, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow up focusing on natural history and circulating hormones. Fertil Steril. 1992; 57: 505-13.

[22] Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005; 83: 1717-23.

[23] Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha -re duction but not the elevated adrenal steroid production rates. J Clin Endocrinol Metab. 2003; 88: 5907-13.

[24] Manni L, Cajander S, Lundeberg T, Naylor AS, Aloe L, Holmang A, et al. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha (1) - and beta (2)-adrenergic receptors in rats with steroid-induced polycystic ovaries. J Neu roendocrinol. 2005; 17: 846-58.

[25] Vrbıkova J, Cibula D, Combined oral contraceptives in the treament of polycystic ovary syndrome, Hum Reprod Update. 2005; 11:

[26] Togas T, Sundus AT, Surgical Managemnet of PCOD, Baillire’s Clin Obs Gynaecol 1998; 12(4): 541-547.

@article{1708699,
      author = {Kiran Singh, Annu Priya},
      title = {Understanding PCOD: Causes and Symptoms},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {11},
      pages = {1650-1656},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1708699.pdf},
      abstract = {Millions of women worldwide experience in PCOD, is a prevalent endocrine ailment that typically impacts women of reproductive age. Hormonal imbalances that cause ovarian cysts, insulin resistance, skin conditions such as acne hirsutism, irregular periods of menstruation, and possible fertility problems are its defining features. Although the precise origin of PCOD is yet unknown, lifestyle and genetic factors are thought to be important. Reducing long-term consequences such type 2 diabetes, cardiovascular disease, and infertility needs early diagnosis and therapy through modifications to the lifestyle, medication therapies, and routine monitoring. In addition to stressing the value of early detection and awareness, this article emphasize the clinical features, probable causes, and treatment procedures for PCOD.},
      keywords = {Polycystic Ovarian Disease (PCOD), Hormonal imbalance, Androgen, Metabolic disorder},
      month = {May},
  }